Atlas Trials

Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation

Clinical trial NCT04792190 · COMPLETED

Trial details

NCT number
NCT04792190
Sponsor
University of Rochester
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2021-07-27
Primary completion
2023-03-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.